BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 14749503)

  • 41. Clinical Variability in Cardiovascular Disease Risk Factor Screening and Management in Adolescent and Young Adult Women with Polycystic Ovary Syndrome.
    Baer TE; Milliren CE; Walls C; DiVasta AD
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):317-23. PubMed ID: 26081478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of supplemented isoenergetic diets varying in cereal fiber and protein content on the bile acid metabolic signature and relation to insulin resistance.
    Weickert MO; Hattersley JG; Kyrou I; Arafat AM; Rudovich N; Roden M; Nowotny P; von Loeffelholz C; Matysik S; Schmitz G; Pfeiffer AFH
    Nutr Diabetes; 2018 Mar; 8(1):11. PubMed ID: 29549243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overweight and obesity and the burden of disease and disability in elderly men.
    Goya Wannamethee S; Gerald Shaper A; Whincup PH; Walker M
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1374-82. PubMed ID: 15356666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why does obesity increase the risk for cardiovascular disease?
    Boden G; Salehi S
    Curr Pharm Des; 2013; 19(32):5678-83. PubMed ID: 23448485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study.
    Gutiérrez-Repiso C; Soriguer F; Rojo-Martínez G; García-Fuentes E; Valdés S; Goday A; Calle-Pascual A; López-Alba A; Castell C; Menéndez E; Bordiú E; Delgado E; Ortega E; Pascual-Manich G; Urrutia I; Mora-Peces I; Vendrell J; Vázquez JA; Franch J; Girbés J; Castaño L; Serrano-Ríos M; Martínez-Larrad MT; Catalá M; Carmena R; Gomis R; Casamitjana R; Gaztambide S
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):947-55. PubMed ID: 24984822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obesity and cancer: the risks, science, and potential management strategies.
    McTiernan A
    Oncology (Williston Park); 2005 Jun; 19(7):871-81; discussion 881-2, 885-6. PubMed ID: 16053036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of a 12-month moderate weight loss intervention on insulin sensitivity and inflammation status in nondiabetic overweight and obese subjects.
    Ho TP; Zhao X; Courville AB; Linderman JD; Smith S; Sebring N; Della Valle DM; Fitzpatrick B; Simchowitz L; Celi FS
    Horm Metab Res; 2015 Apr; 47(4):289-96. PubMed ID: 24977656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome.
    Brinkworth GD; Noakes M; Buckley JD; Clifton PM
    Am Heart J; 2006 Oct; 152(4):693.e1-6. PubMed ID: 16996838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose: A Pilot Study.
    Cabrera-Rode E; Rodríguez J; Álvarez A; Echevarría R; Reyes AD; Cubas-Dueñas I; Turcios-Tristá SE; Díaz-Díaz O
    J Diet Suppl; 2017 Nov; 14(6):626-639. PubMed ID: 28384000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women.
    McLaughlin T; Abbasi F; Carantoni M; Schaaf P; Reaven G
    J Clin Endocrinol Metab; 1999 Feb; 84(2):578-81. PubMed ID: 10022419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parents' cardiovascular risk factors are related to overweight and obesity in young Brazilians with type 1 diabetes.
    Valente F; Valente T; Crispim F; Bittencourt CS; Piveta VM; Moises RCMS; de Sá JR; Dib SA
    J Diabetes Complications; 2022 Jan; 36(1):108082. PubMed ID: 34865986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications.
    Abate N
    J Diabetes Complications; 2000; 14(3):154-74. PubMed ID: 10989324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Obesity, insulin resistance, and its link to non-insulin-dependent diabetes mellitus.
    Walker M
    Metabolism; 1995 Sep; 44(9 Suppl 3):18-20. PubMed ID: 7674911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlations between surrogate measures of insulin resistance and cardiovascular risk factors in obese and overweight patients.
    Lerman I; Villa AR; Ríos Torres JM; Tamez LE; Gómez Pérez F; del Villar Velasco SL; Rull Rodrigo JA
    J Diabetes Complications; 2003; 17(2):66-72. PubMed ID: 12614971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.
    Ryan DH; Espeland MA; Foster GD; Haffner SM; Hubbard VS; Johnson KC; Kahn SE; Knowler WC; Yanovski SZ;
    Control Clin Trials; 2003 Oct; 24(5):610-28. PubMed ID: 14500058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals.
    Farin HM; Abbasi F; Reaven GM
    Am J Cardiol; 2006 Oct; 98(8):1053-6. PubMed ID: 17027570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
    Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.
    Wannamethee SG; Shaper AG; Walker M
    J Epidemiol Community Health; 2005 Feb; 59(2):134-9. PubMed ID: 15650145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.